Article thumbnail
Location of Repository

Transient binding patches: a plausible concept for drug binding

By Heino Prinz and André Schönichen

Abstract

Dose–response curves for inhibitors (drugs) generally are analyzed by means of four-parameter fits, yielding IC50, background, amplitude, and Hill coefficient. Hill coefficients ≠1 contradict 1:1 competition. If binding of substrates to proteins is a stepwise process where initial binding to initial locations (patches) leads to strong binding on defined sites, then drugs (non-endogenous inhibitors) may bind to those presumably larger patches and need not follow a 1:1 stoichiometry for specific inhibition. This concept was translated into three computable models and successfully fitted to 1,282 phosphatase dose–response curves. The models only required four parameters, namely, the equilibrium dissociation constant KD(1) of the first inhibitor binding step, background, amplitude, and a compound interaction factor to quantify the interaction of inhibitors on those patches. Binding of one established inhibitor to the vaccinia virus VH1-related (VHR) phosphatase was directly measured with microcalorimetry, confirming multiple inhibitor binding with equilibrium constants obtained from corresponding inhibition curves

Topics: Original Article
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:2698315
Provided by: PubMed Central

Suggested articles

Citations

  1. (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays.
  2. (1995). An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule.
  3. (1992). Calcium currents in the A7r5 smooth muscle-derived cell line. An allosteric model for calcium channel activation and dihydropyridine agonist action.
  4. (1994). Complex molecular mechanism for dihydropyridine binding to L-type Ca 2+-channels as revealed by fluorescence resonance energy transfer.
  5. (2008). Correlation coefficients in http://en.wikipedia.org/wiki/Correlation_ coefficient
  6. (2008). Description of MODOR, a flexible docking program http:// mondale.ucsf.edu/index_mordor.html
  7. (2005). Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase A (MptpA) inhibitors based on natural products and a fragment-based approach.
  8. (2006). Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis.
  9. (2000). Drug discovery: a historical perspective.
  10. (2005). High-throughput assays for promiscuous inhibitors.
  11. (2007). High-throughput screening assays for the identification of chemical probes.
  12. (2008). How to identify a pharmacophore.
  13. (1995). Kinetics for the life sciences: receptors, transmitters and catalysts.
  14. (1993). Ligand-induced accelerated dissociation of (+)-cis-diltiazem from L-type Ca 2+ channels is simply explained by competition for individual attachment points.
  15. (1987). Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
  16. (1992). Maelicke A
  17. (2003). Mechanistic considerations in high-throughput screening.
  18. (2004). Methods for analyzing cooperativity in phosphoglycerate dehydrogenase.
  19. (1965). On the nature of allosteric transitions: a plausible model.
  20. (1905). On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curare.
  21. (1991). Positive heterotropic allosteric regulators of dihydropyridine binding increase the
  22. (1992). Receptor-binding kinetics. In: Hulme EC (ed) Receptor-ligand interactions. A practical approach.
  23. (1997). The Hill equation revisited: uses and misuses.
  24. (1910). The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.